Valued at $407.0M at its later-stage round, Apr 2025. Nothing has traded since.
- ·The complete investor list: 36 names
- ·Watch Biolinq: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Biolinq funding history
8 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Mar 2025 | Later Stage VC | $90.0M | ▮ | ▮ |
| Dec 2023 | Debt | $59.1M | ▮ | ▮ |
| Sep 2021 | Later Stage VC | $77.9M | ▮ | ▮ |
| Mar 2021 | Debt | $5.2M | ▮ | ▮ |
| Mar 2020 | Debt | $3.6M | ▮ | ▮ |
| Mar 2019 | Seed Round | $3.0M | ▮ | ▮ |
| + 2 earlier rounds · a free account shows the full history | ||||
Membership and data by Private Market View
Biolinq valuation
Biolinq was valued at $407 million at its later-stage round in Apr 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Biolinq raised?
Biolinq has raised $313 million across 8 recorded rounds since 2016. The largest was a $90 million later-stage round in Mar 2025.
Biolinq has filed 12 Form Ds with the SEC since 2016, most recently in Mar 2025 ($90 million sold to 45 investors).
How Biolinq's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Biolinq, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Biolinq
- What is Biolinq worth?
- Biolinq is valued at $407.0M as of Oct 2026. Valued at $407.0M at its later-stage round, Apr 2025. Nothing has traded since.
- How much has Biolinq raised?
- Biolinq has raised $312.8M in total funding across 8 recorded rounds.
- When did Biolinq last raise?
- Biolinq last raised in Mar 2025 (Later Stage VC), raising $90.0M.